Neurogene Inc. Capital Expenditures Incurred but Not yet Paid
Neurogene Inc. (NGNE) reported Capital Expenditures Incurred but Not yet Paid of $43.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-08-11
- Neurogene Inc. capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was -$311.00K, a 747.92% decline year-over-year.
- Neurogene Inc. capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $354.00K, a 342.50% increase year-over-year.
- Neurogene Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was $76.00K, a 230.43% increase year-over-year.
- Neurogene Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was -$128.00K, a 120.25% decline year-over-year.
- Neurogene Inc. capital expenditures incurred but not yet paid for fiscal 2025 was $76.00K, a 89.53% decline from fiscal 2024.
- Neurogene Inc. capital expenditures incurred but not yet paid for fiscal 2024 was $726.00K.
- Neurogene Inc. capital expenditures incurred but not yet paid for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Neurogene Inc. capital expenditures incurred but not yet paid for fiscal 2022 was $283.00K, a 31.31% decline from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 3 month as first filed | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 6 month as first filed | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$311.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $43.00K 10-Q · filed 2026-08-11 | $119.00K derived: sum of 3 quarters · filed 2026-08-11 | -$9.00K derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2026-03-31 | $354.00K 10-Q · filed 2026-05-12 | $430.00K derived: sum of 2 quarters · filed 2026-05-12 | $302.00K derived: sum of 3 quarters · filed 2026-05-12 | $350.00K derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-12-31 | $76.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$52.00K derived: sum of 2 quarters · filed 2026-03-24 | -$4.00K derived: sum of 3 quarters · filed 2026-08-11 | $76.00K 10-K · filed 2026-03-24 | ||
| 2025-09-30 | -$128.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$80.00K derived: sum of 2 quarters · filed 2026-08-11 | $0.00 10-Q · filed 2025-11-13 | $23.00K derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-06-30 | $48.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $128.00K 10-Q · filed 2026-08-11 | $151.00K derived: sum of 3 quarters · filed 2026-08-11 | $783.00K derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-03-31 | $80.00K 10-Q · filed 2026-05-12 | $103.00K derived: sum of 2 quarters · filed 2026-05-12 | $735.00K derived: sum of 3 quarters · filed 2026-05-12 | $665.00K derived: sum of 4 quarters · filed 2026-05-12 | ||
| 2024-12-31 | $23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $655.00K derived: sum of 2 quarters · filed 2026-03-24 | $585.00K derived: sum of 3 quarters · filed 2026-03-24 | $726.00K 10-K · filed 2026-03-24 | ||
| 2024-09-30 | $632.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $562.00K derived: sum of 2 quarters · filed 2025-11-13 | $703.00K 10-Q · filed 2025-11-13 | $703.00K derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | -$70.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $71.00K 10-Q · filed 2025-08-11 | $71.00K derived: sum of 3 quarters · filed 2025-08-11 | $19.00K derived: sum of 4 quarters · filed 2025-08-11 | ||
| 2024-03-31 | $141.00K 10-Q · filed 2025-05-09 | $141.00K derived: sum of 2 quarters · filed 2025-05-09 | $89.00K derived: sum of 3 quarters · filed 2025-05-09 | $141.00K derived: sum of 4 quarters · filed 2025-05-09 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | -$52.00K derived: sum of 2 quarters · filed 2025-03-24 | $0.00 derived: sum of 3 quarters · filed 2025-03-24 | $0.00 10-K · filed 2025-03-24 | ||
| 2023-09-30 | -$52.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-18 | $0.00 derived: sum of 2 quarters · filed 2024-11-18 | $0.00 10-Q · filed 2024-11-18 | $255.00K derived: sum of 4 quarters · filed 2024-11-18 | ||
| 2023-06-30 | $52.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $52.00K 10-Q · filed 2024-08-09 | $0.00 10-Q · filed 2023-08-10 | $307.00K derived: sum of 3 quarters · filed 2024-08-09 | $70.00K derived: sum of 4 quarters · filed 2024-08-09 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-10 | $99.00K 10-Q · filed 2023-05-08 | $255.00K derived: sum of 2 quarters · filed 2024-05-10 | $18.00K derived: sum of 3 quarters · filed 2024-05-10 | $192.00K derived: sum of 4 quarters · filed 2024-05-10 | |
| 2022-12-31 | $255.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $18.00K derived: sum of 2 quarters · filed 2023-11-14 | $192.00K derived: sum of 3 quarters · filed 2023-11-14 | $283.00K 10-K · filed 2023-03-20 | ||
| 2022-09-30 | -$237.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$63.00K derived: sum of 2 quarters · filed 2023-11-14 | $28.00K 10-Q · filed 2023-11-14 | $143.00K derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | $174.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $265.00K 10-Q · filed 2023-08-10 | $380.00K derived: sum of 3 quarters · filed 2023-08-10 | $258.00K derived: sum of 4 quarters · filed 2023-08-10 | ||
| 2022-03-31 | $91.00K 10-Q · filed 2023-05-08 | $206.00K derived: sum of 2 quarters · filed 2023-05-08 | $84.00K derived: sum of 3 quarters · filed 2023-05-08 | -$291.00K derived: sum of 4 quarters · filed 2023-05-08 | ||
| 2021-12-31 | $115.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | -$7.00K derived: sum of 2 quarters · filed 2023-03-20 | -$382.00K derived: sum of 3 quarters · filed 2023-03-20 | $412.00K 10-K · filed 2023-03-20 | ||
| 2021-09-30 | -$122.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$497.00K derived: sum of 2 quarters · filed 2022-11-14 | $297.00K 10-Q · filed 2022-11-14 | $62.00K derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | -$375.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $419.00K 10-Q · filed 2022-08-09 | $184.00K derived: sum of 3 quarters · filed 2022-08-09 | $50.00K derived: sum of 4 quarters · filed 2022-08-09 | ||
| 2021-03-31 | $794.00K 10-Q · filed 2022-05-09 | $559.00K derived: sum of 2 quarters · filed 2022-05-09 | $425.00K derived: sum of 3 quarters · filed 2022-05-09 | $830.00K derived: sum of 4 quarters · filed 2022-05-09 | ||
| 2020-12-31 | -$235.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$369.00K derived: sum of 2 quarters · filed 2022-03-01 | $36.00K derived: sum of 3 quarters · filed 2022-03-01 | $36.00K 10-K · filed 2022-03-01 | ||
| 2020-09-30 | -$134.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $271.00K derived: sum of 2 quarters · filed 2021-11-04 | $271.00K 10-Q · filed 2021-11-04 | |||
| 2020-06-30 | $405.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $405.00K 10-Q · filed 2021-08-05 | ||||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-12 | |||||
| 2019-12-31 | $0.00 10-K · filed 2021-03-25 | |||||
| 2017-06-30 | $53.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $77.00K 10-Q · filed 2017-08-08 | $51.00K derived: sum of 3 quarters · filed 2017-08-08 | |||
| 2017-03-31 | $24.00K 10-Q · filed 2017-05-09 | -$2.00K derived: sum of 2 quarters · filed 2017-05-09 | ||||
| 2016-12-31 | -$26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $77.00K 10-K · filed 2017-03-09 | ||||
| 2016-09-30 | $103.00K 10-Q · filed 2016-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |